Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis
NCT ID: NCT03234517
Last Updated: 2018-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
200 participants
INTERVENTIONAL
2016-08-01
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole
NCT07247851
Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy
NCT01558388
A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)
NCT01293643
Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network
NCT00503542
A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women
NCT02210689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vaginal Clindamycin Cream Plus continuous Vaginal Probiotic
Vaginal Clindamycin Cream followed by continuous Vaginal Probiotic use for 60 days
Vaginal Clindamycin Cream
Vaginal Clindamycin Cream
Vaginal Probiotic
Vaginal Probiotic
Vaginal Clindamycin Cream Plus interrupted Vaginal Probiotic
Vaginal Clindamycin Cream followed by interrupted Vaginal Probiotic use
Vaginal Clindamycin Cream
Vaginal Clindamycin Cream
Vaginal Probiotic
Vaginal Probiotic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vaginal Clindamycin Cream
Vaginal Clindamycin Cream
Vaginal Probiotic
Vaginal Probiotic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* has recurrent Bacterial Vaginosis
Exclusion Criteria
* use of other antmicrobial
* not provide informed consent
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
IBRAHIM ABD ELGAFOR
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ibrahim A EL sharkwy
Role: PRINCIPAL_INVESTIGATOR
FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zagazig University
Zagazig, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
zuh- 8
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.